Introduction
Gastric cancer is one of the most common cancers worldwide. Although the occurrence rate of gastric cancer has decreased in recent years, the incidence of the disease is still high in Asian countries such as Korea and Japan (1) . However, relatively little is known regarding genetic susceptibility in the pathogenesis of gastric cancer (2) . Mutations in the calcium-dependent cell adhesion molecule, E-cadherin, have been associated with the early development of gastric cancer (3) . E-cadherin germline mutations were first identified in New Zealand Maori families with early-onset diffuse gastric cancer; since then, the majority of E-cadherin germline mutations have been reported in diffuse type gastric cancer (4EE7). Recently, we reported a MET germline mutation as well as E-cadherin germline mutations in the diffuse type of familial gastric cancer (FGC) (6, 8) . E-cadherin is found predominantly in epithelial cells and plays a pivotal role in maintaining tissue integrity (9) . A large number of reports have identified downregulation of E-cadherin expression in human carcinomas, and E-cadherin function is lost during the development of most epithelial cancers. Indeed, it is thought that loss of E-cadherin function in cancer cells probably plays an important role in tumor development and progression (10) . However, it is not yet understood how these losses of expression are governed. Just as nucleotide variations in the coding region of a gene can alter protein function, polymorphisms within the 5 H -promoter region have been known to change the transcriptional efficiency of a variety of genes (11, 12) . Recently, two frequent polymorphisms in human cancers have been identified in the promoter region of the E-cadherin gene. The first is a C3A single nucleotide polymorphism (SNP) À160 nt from the transcriptional start site of the E-cadherin gene promoter; transcription of the A allele is 68% less efficient than that of the C allele (13) . The second reported promoter variant is a G3GA SNP À347 nt from the transcriptional start site of the E-cadherin gene. The original report suggested that this polymorphism had no effect on transcriptional activity (14) . In this study, we sought to better understand the mechanisms of altered E-cadherin expression by investigating À347 G3GA polymorphism effects on E-cadherin transcriptional activity.
Materials and methods

DNA isolation from blood samples
Blood samples of 28 cases from 27 FGC families without germline mutations in the E-cadherin coding sequence (8) and 142 normal control individuals were collected from the Seoul National University Hospital, South Korea. Informed consent was obtained from all participants prior to testing. Twenty-seven Korean families affected with familial gastric cancer were investigated for genotyping of À347G3GA promoter polymorphism of E-cadherin gene. Criteria for family inclusion were at least two first or second degree relatives affected with gastric cancer, at least one of whom was diagnosed with cancer before the age of 50 (8) . Out of 27 probands (range 22EE69 ages), 12 represented families suffering from diffuse types of gastric cancer, four represented families suffering from intestinal types and histological data for the type of the remaining 11 were not available. The classification of hereditary diffuse gastric cancer or hereditary intestinal gastric cancer was not possible in these families owing to the lack of histological information. The normal control population was randomly selected from 142 healthy Korean individuals. Peripheral blood lymphocytes were isolated from samples using Ficoll-Paque (Pharmacia Biotech, Uppsala, Sweden) according to the manufacturer's instructions. Total genomic DNA was extracted with the Trizol reagent (Invitrogen, Carlsbad, CA) according to the manufacturer's instructions.
DNA analysis of the E-cadherin promoter regions
We screened each of the above samples for the À347G3GA E-cadherin polymorphism using denaturing high-performance liquid chromatography (DHPLC) (WAVE Ò , Transgenomic, Omaha, NE C for 1 min, followed by five cycles of 94 C for 30 s, 55 C for 30 s, 72 C for 1 min, with a final extension of 10 min at 72 C. DHPLC was performed as described previously (15, 16) . For heteroduplex formation, PCR products were denatured at 95 C for 5 min followed by gradual cooling to 25 C over a period of 1 h. All samples were investigated by DHPLC and direct sequencing. Direct sequencing was carried out using a Big-dye terminator cycle sequencing kit and an ABI 3100 DNA sequencer (Perkin-Elmer, Foster, CA).
PCREERFLP
To investigate the frequency of the À160C3A polymorphism, we performed PCREERFLP analysis. PCR primers and conditions were the same as above. PCR products were digested with HincII, and separated on a 3% agarose gel. The A allele yielded two fragments (369 and 79 bp), whereas the C allele was visualized as a single band (448 bp). The results were confirmed by direct sequencing as above.
Transient transfection and dual luciferase reporter assay
To examine the potential effect of the À347G3GA polymorphism on E-cadherin gene transcription, a 794 bp promoter region of the E-cadherin gene (from À647 to 147) carrying either the G or GA allele was inserted upstream of the firefly luciferase gene in the pGL3 Enhancer plasmid vector (Promega, Madison, WI). The G and GA alleles were amplified from DNA samples taken from FGC patients, digested with KpnI and BglII, and cloned into the promoterless pGL3 enhancer plasmid vector. Three different luciferase reporter plasmids were generated: pGL3-G (containing the G allele), pGL3-GA (containing the GA allele) and pGL3-control (Promega), which contains SV40 promoter and enhancer sequences. Each construct was confirmed by sequencing. We performed transient transfections in CV-1, HeLa, SNU-719, AGS and KatoIII cells obtained from Korean Cell Line Bank. HeLa, SNU-719, AGS and KatoIII cells were cultured in RPMI 1640 supplemented with 10% heat-inactivated fetal bovine serum, while CV-1 cells were cultured in DMEM supplemented with 10% heat-inactivated fetal bovine serum. Approximately 5 Â 10 4 cells/well in a 24-well plate were inoculated and cultured for 24 h before transient transfections were performed with the Effectene reagent (Qiagen, Valencia, CA). As an internal standard, all plasmids were cotransfected with pRL-TK, which contains the Renilla luciferase gene. Cells were collected 48 h after transfection, and cell lysates were prepared according to Promega's instruction manual. Luciferase activity was measured with a luminometer (Promega) and normalized against the activity of the Renilla luciferase gene. The pGL3-basic vector (Promega), which lacks both promoter and enhancer, was used as a negative control in each of the transfection experiments. Independent triplicate experiments were performed for each plasmid.
EMSA (electrophoretic mobility shift assay) EMSA was performed using the Gel Shift Assay System (Promega). Complementary oligonucelotide pairs corresponding to the E-cadherin promoter sequence were synthesized (Bioneer, Seoul, South Korea) as follows (bold letters indicate polymorphism): À347G (containing the G allele), 5
H -GGGTG-AAAGAGTGAGCCCCATCTCCAAAAC-3 H , À347GA (containing the GA allele), 5 H -GGGTGAAAGAGTGAGACCCCATCTCCAAAAC-3 H . The oligonucleotide pairs were annealed and labeled with [g-32 P]ATP (Amersham Biosciences, Buckinghamshire, UK). Binding reactions were carried out with HeLa nuclear extracts (Promega) according to the manufacturer's instructions. One microlitre of 32 P-labeled probe was incubated with 5 mg of HeLa nuclear extract for 20 min at room temperature. DNAEEprotein binding specificity was tested by competition assays in which the binding reactions were pre-incubated with 10-, 50-and 100-fold excesses of unlabeled specific or non-specific competitor oligonucleotides prior to the addition of the labeled probe. After the binding reaction was complete, the DNAEEprotein complexes were resolved by electrophoresis in a 4% non-denaturing acrylamide gel. After electrophoresis, the gels were transferred onto 3 M Whatman paper, dried and autoradiographed.
Statistical analysis
The x 2 test for association was used to assess the differences in genotype distribution. The genotypic-specific risks were estimated as odds ratios (OR) with associated 95% confidence intervals (CI) by unconditional logistic regression (17) . The observed genotypes frequencies were compared using a x 2 test to determine if they were in HardyEEWeinberg equilibrium. All tests were performed with the STATISTICA software package (StatSoft Inc., Galvaniweg, UK). A P value 50.05 was considered statistically significant.
Results
Effect of the À347G3GA polymorphism on promoter activity To examine the effect of À347G3GA promoter region polymorphism on transcription of the E-cadherin gene, we measured promoter activity with a Dual Luciferase Reporter Assay System (Promega) and compared the activities of the À347GA and À347G alleles by transient transfection assay in CV-1, HeLa, SNU-719, AGS and KatoIII cells. As shown in Figure 1 , significantly lower luciferase activities were generated by the pGL3-GA construct as compared with the pGL3-G construct. In CV-1 cells, the GA allele decreased the transcriptional efficiency by 10-fold (P 0.000261) compared with the G allele. Similar results were obtained in HeLa, SNU-719, AGS and KatoIII cells (12-, 8-, 9-, 13-fold decrease, respectively).
Effect of the À347G3GA polymorphism on the binding activity of nuclear factors To determine whether the À347G3GA polymorphism affects the binding activity of nuclear factors, synthetic À347G and À347GA oligonucleotides were incubated with HeLa cell nuclear extracts and subjected to EMSA. The À347GA oligonucleotide showed weak DNAEEprotein binding, whereas the À347G oligonucleotide showed stronger DNAEEprotein binding ( Figure 2) . To verify the DNAEEprotein complex, competition assays were performed with specific and non-specific oligonucleotides (Figure 2 ). When a À347G oligonucleotide was used to compete with a À347GA oligonucleotide, it totally disrupted the À347GA oligonucleotide binding with nuclear protein. However, when a À347GA oligonucleotide was used to compete with a À347G oligonucleotide, it was not as effective as a À347G oligonucleotide in disrupting oligonucleotide binding with nuclear protein.
Allele frequencies in FGC samples and normal controls
To determine whether there is a correlation between the promoter polymorphisms and FGC, we screened a 448 bp region (À529 to À82 from the transcriptional start site) of the E-cadherin promoter in 28 cases of FGC and 142 normal controls using PCREERFLP or DHPLC (Figure 3) . We identified the previously reported À160C3A and À347G3GA polymorphisms (13, 14) , and noted a positive association between the À347GA allele and FGC. Eleven (39.4%) of 28 FGC samples were heterozygous at this locus, as compared with 39 (27.5%) of 142 normal controls. Individuals with the E-cadherin genotype (À347G/GA heterozygous or GA homozygous) had an increased risk (P 0.03059) for FGC ( Table I ). The distribution of genotypes was in HardyEEWeinberg equilibrium. In contrast, we did not identify a positive or negative association between the À160C3A polymorphism and FGC (Table I) .
Discussion
In the present study, we focused on the effect of the À347G3GA E-cadherin polymorphism on transcriptional activity. Several major cis-acting elements have been identified within a short section of the proximal promoter of the E-cadherin gene, including two E boxes, a CAAT box, and a GC-rich box SP1 binding site (14, 18) . The E-cadherin gene promoter thus exhibits a modular structure, suggesting that the strict control of epithelium-specific E-cadherin expression might result from interactions among the various regulatory elements (19) . Our results demonstrate that the À347 SNP has a significant effect on transcriptional activity in transient transfection experiments. We performed transient transfections in CV-1, HeLa, SNU-719, AGS and KatoIII cells, because it was EMSA with HeLa nuclear extract using À347G and À347GA oligonucleotides. Binding activity of the À347G and À347GA oligonucleotides. The assay was performed in the presence () or absence (À) of HeLa nuclear extract. Competition assays were performed with unlabeled À347G or À347GA oligonucleotides. Each binding reaction contained 5 mg of HeLa nuclear extract and labeled À347G (lanes 2EE6) or À347GA (lanes 8EE12) oligonucleotides. Excess unlabeled À347G or À347GA oligonucleotides (10-, 50-and 100-fold) were included in the binding reactions as competitor (lanes 3EE5 and 9EE11, respectively). In addition, 100-fold excesses of unlabeled À347GA and À347G oligonucleotides were used to compete with À347G (lane 6) and À347GA (lane 12) oligonucleotides. Arrows indicate DNAEEprotein complexes. See online supplementary material for colour version of this figure. reported previously that the À347 G3GA promoter polymorphism of E-cadherin gene had no effect on transcriptional activity in CV-1 cells (14) . In contrast to previous reported results, our study showed that in CV-1 cells, the GA allele of this polymorphism decreased the transcriptional efficiency by 10 fold (P 0.000261) compared with the G allele ( Figure 1) . Similar results were obtained in HeLa, SNU-719, AGS and KatoIII cells. The molecular mechanism of this difference may relate to differences in the affinity of DNA-binding proteins to the two alleles of the E-cadherin promoter. We searched for putative transcriptional factors that might bind with the À347 SNP, using the Ds gene software package (Accelrys, San Diego, CA). We identified four putative transcription factors (Site_C2, ZESTE_CS, T-Ag-SV40.3, T-Ag-EP) with similarities to sequences near the E-cadherin À347G3GA promoter polymorphism. These putative transcription factors are not well characterized, and their in-depth study may be a target of future work. To investigate binding between the alleles and nuclear factors in general, we performed EMSA, which revealed that the À347GA allele bound nuclear factors more weakly than the À347G allele. In competition assay, the À347G allele was able to disrupt À347GA-protein binding, whereas the À347GA allele was less able to disrupt nuclear protein binding to the À347G allele. Although further work will be necessary to investigate the exact molecular mechanism by which activity of E-cadherin is affected by the allelic variation, our results suggest that the À347GA polymorphism may negatively impact transcription factor binding, leading to a decrease in E-cadherin expression. Lastly, we examined whether the À347G3GA promoter polymorphism of the E-cadherin gene was associated with FGC. Individuals with the E-cadherin genotype (EE347G/GA heterozygous or GA homozygous) had an increased risk for FGC. In the case of the À160C3A polymorphism, several reports have investigated the correlation between the À160C3A polymorphism of the E-cadherin and gastric cancer (2, 17, 20) . However, the correlation between the À160C3A polymorphism of the E-cadherin and gastric cancer is still controversial. We found that the genotype frequency of À160C3A polymorphism did not differ between the normal controls and FGC patients (Table I) . However, the sample number was too small to determine the statistical significance of these differences. In the future, larger population studies will be required to confirm whether these variants increase the risk of cancer in Korean and other ethnic groups.
In summary, we investigated the importance of the À347G3GA polymorphism in the promoter region of the Ecadherin gene. The GA allele was associated with significant suppression of E-cadherin transcription in CV-1, HeLa, SNU-719, AGS and KatoIII cells. Additionally, EMSA revealed that the GA allele had a weak transcriptional factor binding strength compared with the G allele. Therefore, it seems that À347G3GA polymorphism may affect the expression of Ecadherin, possibly increasing the cancer risk.
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